Cas:34377-38-3 isoamyl salicylate manufacturer & supplier

We serve Chemical Name:isoamyl salicylate CAS:34377-38-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

isoamyl salicylate

Chemical Name:isoamyl salicylate
CAS.NO:34377-38-3
Synonyms:isoamyl salicylate
Molecular Formula:C12H16O3
Molecular Weight:208.25400
HS Code:2918230000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:277-278ºC(lit.)
Density:1.05 g/mL at 25ºC(lit.)
Index of Refraction:n20/D 1.507(lit.)
PSA:46.53000
Exact Mass:208.11000
LogP:2.59510

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3082 9/PG 3
Packing Group:


Contact us for information like isoamyl salicylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,isoamyl salicylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,isoamyl salicylate Use and application,isoamyl salicylate technical grade,usp/ep/jp grade.


Related News: FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. isoamyl salicylate manufacturer Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. isoamyl salicylate supplier Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. isoamyl salicylate vendor Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. isoamyl salicylate factory Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development.